Logos Global Management LP Vaxcyte, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$18.66 - $29.16 $2.61 Million - $4.08 Million	-140,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$26.57 - $51.74 $3.72 Million - $7.24 Million	140,000 New	140,000 $3.72 Million
Q3 2020 Nov 16, 2020	SELL	$26.5 - $55.4 $12.1 Million - $25.2 Million	-455,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$26.15 - $35.45 $11.9 Million - $16.1 Million	455,000 New	455,000 $14.4 Million

299

110M

246K

118K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $6.33B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.